Health Care: Health Services

Bio-Reference Laboratories Inc (BRLI: NASDAQ)

$35.17 0.52 | 1.5%
03/27/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 34.65
52 Week High 36.75
52 Week Low 24.19
Avg. Daily Vol. (Mil) 0.27
Beta (3 year) 0.52
Share Related Items
Mkt Cap (Mil) 962.47
Shares Out (Mil) 27.78
Float (Mil) 24.64
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.00
Current Ratio 2.40
LT Debt/ Equity 0.05
Total Debt / Equity 0.17
Valuation Ratios
Price Earnings 19.10
Price/Sales 1.12
Price/Book 2.95
Price/Cash Flow 12.60
Per Share Data
Earnings 1.81
Sales 30.96
Book Value 11.73
Cash Flow 2.75
Business Summary
Bio-Reference Laboratories Inc is engaged in providing laboratory testing services. The Company offers chemical diagnostic tests including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis and toxicology.
General Information
481 Edward H. Ross Drive
Elmwood Park, NJ 07407
www.bioreference.com
Industry : Health Services
Sector: Health Care
Employees: 3406
CEO: Dr. Marc D. Grodman,M.D.
Short Interest
Current Month (Mil) 4.82
Previous Month (Mil) 4.73
Short Interest Ratio (Days) 15.30
Management Effectiveness
Return on Equity 15.50
Return on Assets 10.30
Return on Investments 14.80
Profitability
Gross Margin 47.40
EBIT Margin 10.40
Profit Margin 5.90

Portfolios with BRLI

Latest BRLI Headlines from TheStreet

More Financial News for BRLI

Press Releases for BRLI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter